eaikawa at bwh.harvard.edu

Residual Bioprosthetic Valve Immunogenicity: Forgotten, Not Lost

January 4, 2022

Human P, Bezuidenhout D, Aikawa E, Zilla P.

Front Cardiovasc Med. 2022 Jan 4;8:760635. PMID: 35059444. PMC8764456.

previous post: Controlled Delivery of Gold Nanoparticle-Coupled miRNA Therapeutics via an Injectable Self-Healing Hydrogel
next post: Proinflammatory Matrix Metalloproteinase-1 Associates With Mitral Valve Leaflet Disruption Following Percutaneous Mitral Valvuloplasty